Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-26 @ 3:57 AM
Study NCT ID:
NCT03531918
Status:
COMPLETED
Last Update Posted:
2023-08-30
First Post:
2018-05-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-09
First Submit QC Date:
None
Study First Post Date:
2018-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-30
Results First Submit QC Date:
None
Results First Post Date:
2022-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-10
Last Update Post Date:
2023-08-30
Last Update Post Date Type:
ACTUAL